Table 1.

Summary of recently published trials [30–33]

	UKPDS	ACCORD [31]	ADVANCE [32]	VADT [33]
	Follow-up [30]
Number of patients	3,277	10,251	11,140	1,791
Mean (SD) age, years	62.0 (8)	62.2 (6.8)	66.0 (6)	60.5 (9)
Duration of diabetes on entry, years	Newly diagnosed	10.0	8.0	11.5
Cardiovascular outcome	Benefit	Harm	No benefit	No benefit

ACCORD Action to Control Cardiovascular Risk in Diabetes, ADVANCE Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation, UKPDS UK Prospective Diabetes Study, VADT Veterans Affairs Diabetes Trial